teva-pharma-to-close-its-206-000-square-feet-sellersville-facility-by-2017

Teva to shut down US site, cut many jobs

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Teva Pharmaceutical Industries decided to close its manufacturing and research facility in Sellersville, Bucks County, US, by 2017, as the net income... Read more

abide-therapeutics-entered-into-an-agreement-with-merck-msd-to-discover-develop-and-commercialize-small-molecule-therapies-for-type-2-diabetes

Merck to pay up to $430 mn to Abide for diabetes deal

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Abide Therapeutics, a biopharmaceutical company pioneering innovative approaches to selectively target a group of enzymes known as serine hydrolases,... Read more

pfizer-us-may-reach-a-final-decision-on-whether-or-not-to-split-itself-into-brand-name-and-generics-businesses-only-by-2016

Pfizer US may split its generics business

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Pfizer, US, is contemplating the thought of splitting itself into brand name and generics businesses. Mr Frank D'Amelio, chief financial officer, Pfizer,... Read more

pharmaceutical-product-development-s-ppd-has-been-ranked-second-in-centerwatch-s-2013-global-investigative-site-relationship-survey-for-reputation-among-all-contract-research-organizations-cros

PPD ranked 2nd by CenterWatch CRO site survey

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Pharmaceutical Product Development's (PPD) site has been acknowledged by CenterWatch's 2013 Global Investigative Site Relationship Survey for reputation... Read more

bausch-lomb-to-distribute-physiol-s-finevision-trifocal-and-finevision-trifocal-toric-hydrophilic-aspheric-intraocular-lenses-iols

Bausch+Lomb to distribute PhysIOL lense in Asia

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Bausch + Lomb, the global eye health company has been appointed as distributor of several lines of intraocular lense manufacturer, PhysIOL's hydrophilic... Read more

qiagen-to-use-ingenuity-systems-knowledge-base-to-analyze-next-generation-sequencing-ngs-data

Qiagen buys biology software firm for $105 mn

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Qiagen has acquired US-based Ingenuity Systems, a leading provider of software solutions to efficiently and accurately analyze and interpret genomic data.... Read more

fda-approves-pjia-drug

First FDA nod for juvenile arthritis drug in 5 years

  • US
  • |
  • Regulatory
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Genentech, a member of the Roche Group received approval for its polyarticular juvenile idiopathic arthritis (PJIA) drug Actemra (tocilizumab) from the... Read more

plastic-surgeons-use-facebook-linkedin-twitter-youtube-and-other-social-media-platforms-to-enhance-their-practice

50% surgeons market their practice via social media

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: A survey conducted by Plastic and Reconstructive Surgery, which is the official medical journal of the American Society of Plastic Surgeons (ASPS), has... Read more

deficiencies-in-documentation-and-validation-of-quality-testing-procedures-leads-fda-to-reject-gilead-hiv-ndas-for-elvitegravir-and-cobicistat

Lack of documents leads FDA to reject Gilead HIV NDAs

  • US
  • |
  • Regulatory
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Gilead Sciences received complete response letters from the US FDA for its New Drug Applications (NDAs) for elvitegravir and cobicistat for use as part... Read more

Special Features

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X